Goodwin Procter LLP Associate Katherine Maxwell, from Boston, practices in business law. Learn more about Katherine's experience, recent cases & contact details today.

Katherine Maxwell

Counsel
Katherine Maxwell
Boston
+1 617 570 1167

Katie Maxwell is counsel in the firm’s Business Law department and a member of its Technology & Life Sciences group. Katie advises clients on a wide range of corporate matters, including company formation, venture capital financings, mergers and acquisitions, strategic transactions, public securities offerings, and general corporate and securities law. She also represents venture capital, corporate and other strategic investors, advising them on structuring and executing their investment transactions. She joined Goodwin in 2016.

Representative Matters

  • Toast in its $400 million Series F financing and other preferred stock financings
  • Dutchie in its $350 million Series D financing
  • Openly in its $100 million Series D financing and other preferred stock financings
  • Firefly Health in its preferred stock financings
  • Klaviyo in its strategic transaction and financing with Shopify
  • Petfolk in its $40 million Series B financing
  • Machinery Partner in its $11 million Series A financing
  • Clockworks Analytics in its Series E financing
  • Jobber in its $100 million Series D financing
  • HotSpot Therapeutics in its $100 million Series C financing and other preferred stock financings
  • Lynx FinHealth in its $17.5 Million Series A financing and other preferred financings
  • Judy Security in its formation and preferred stock financings
  • Aliro Quantum in its formation and preferred stock financings
  • GoodMylk in its preferred stock financings
  • Hedron Space in its $17.8 million Series A financing
  • Kymera Therapeutics in its $65 million Series B financing and other preferred stock financings
  • Allurion Technologies in its $27 million Series C financing
  • Neon Therapeutics in its $106 million Series B financing

Katie has also represented Bessemer Venture Partners, Lightspeed Ventures, Vinyl Ventures, HubSpot Ventures, Ascenta Capital, Deerfield Management Company, Curie.Bio, Point 406 Ventures, Hamilton Lane and other venture capital and strategic investors in various investments in portfolio companies.

  • Toast in its $1 billion initial public offering
  • Kymera Therapeutics in its $200 million initial public offering
  • Neon Therapeutics in its $100 million initial public offering
  • Underwriting syndicate in the $115 million follow-on offering and subsequent $125 million follow-on offering by Everbridge
  • Underwriting syndicate in the $450 million 144A offering by Everbridge

  • AppNexus in its sale to AT&T
  • Roman DBDR Tech Acquisition Corp. (a SPAC) in its business combination with Composecure
  • MarkForged (NYSE: MKFG) in its acquisition of Digital Metal
  • Minim in its sale to Zoom Telephonics (NASDAQ: MINM)
  • A virtual health care company in its sale to a public company
  • Iconics in its sale to Mitsubishi Electric Corporation
  • SimpliSafe in its sale to Hellman & Friedman
  • Qvidian in its sale to Upland Software (NASDAQ: UPLD)
  • A financial services company in the sale of one of its business units to another financial services company

Credentials

Education

JD2016

University of Virginia School of Law

BA2011

Connecticut College

(magna cum laude)

Admissions

Bars

  • Massachusetts